环维黄杨星D与HMGB1的相互作用研究-国际医药研究前沿-CSCIED科技核心评价数据库-手机版

登录 | 注册

环维黄杨星D与HMGB1的相互作用研究

Study on the interaction between cyclovirobuxine D and HMGB1

ES评分 0 浏览量：464 下载量：0

全文阅读下载引用收藏

DOI	10.12208/j.imrf.20240014
刊名	国际医药研究前沿 International Medical Research Frontier
年，卷(期)	2024, 8(2)
作者	孟艳艳*,张剑,
作者单位	中国药科大学江苏南京 ;
摘要	HMGB1（High mobility group box1 protein 1）作为DAMPs（Damageassociated molecular pattern, DAMPs），介导细胞间损伤与炎症信号的传递，在无菌炎症、自身免疫性疾病及癌症等病理过程中发挥关键作用，并作为药物靶点与生物标志物具有广泛研究价值。环维黄杨星D (cyclovirobuxine D, CVB-D)广泛应用于预防和治疗各种心血管疾病，具有显著的抗炎潜力。但目前暂时没有CVB-D与HMGB1相互作用的研究。故本研究在细胞水平和分子水平探究CVB-D与HMGB1相互作用及其分子机制。结果表明CVB-D抑制HMGB1诱导的炎症反应，这可能CVB-D能与HMGB1结合且能改变其构象有关。
Abstract	As DAMPs, HMGB1 mediates the transmission of intercellular damage and inflammatory signals, plays a key role in pathological processes such as aseptic inflammation, autoimmune diseases and cancer, and has extensive research value as a drug target and biomarker. CVB-D is widely used in the prevention and treatment of various cardiovascular diseases, and has significant anti-inflammatory potential. However, there is currently no study on the interaction between CVB-D and HMGB1. Therefore, this study explored the interaction between CVB-D and HMGB1 and its molecular mechanism at the cellular and molecular levels. The results showed that CVB-D inhibited HMGB1-induced inflammatory response, which may be related to the fact that CVB-D can bind to HMGB1 and change its conformation.
关键词	HMGB1；CVB-D；小分子-蛋白相互作用
KeyWord	HMGB1; CVB-D; Small molecule-protein interaction
基金项目
页码	14-17

参考文献
相关文献

引用本文

孟艳艳*,张剑. 环维黄杨星D与HMGB1的相互作用研究 [J]. 国际医药研究前沿. 2024; 8; (2). 14 - 17.

文献评论

相关学者

相关机构